Hyderabad Pharma Infrastructure And Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-07-2024
- Paid Up Capital ₹ 0.50 M
as on 01-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 25.55%
(FY 2022)
- Profit 79.91%
(FY 2022)
- Ebitda 272.15%
(FY 2022)
- Net Worth -0.94%
(FY 2022)
- Total Assets -0.72%
(FY 2022)
About Hyderabad Pharma Infrastructure And Technologies
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kappuram Shyam, Anandakumar Attivarapu, Policepatil Bakkareddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U45200TG2005NPL045814
- Company No.
045814
- Company Classification
Public Not For Profit Company
- Incorporation Date
04 Apr 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyderabad Pharma Infrastructure And Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakthi Nagappan  | Managing Director | 10-Apr-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenivasu Garikapati | Nominee Director | 04-Mar-2022 | Current |
| Kappuram Shyam | Nominee Director | 10-Apr-2019 | Current |
| Anandakumar Attivarapu | Nominee Director | 10-Apr-2019 | Current |
| Policepatil Bakkareddy | Nominee Director | 10-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Hyderabad Pharma Infrastructure And Technologies.
Hyderabad Pharma Infrastructure And Technologies, for the financial year ended 2022, experienced significant growth in revenue, with a 25.55% increase. The company also saw a substantial improvement in profitability, with a 79.91% increase in profit. The company's net worth dipped by a decrease of 0.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Pharma Infrastructure And Technologies?
In 2017, Hyderabad Pharma Infrastructure And Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jeedimetla Effluent Treatment Limited.Active 37 years 10 monthsPolicepatil Bakkareddy is a mutual person
Telangana Life Sciences Infrastructure Development LimitedActive 6 years 7 monthsKappuram Shyam and Shakthi Nagappan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hyderabad Pharma Infrastructure And Technologies?
Unlock and access historical data on people associated with Hyderabad Pharma Infrastructure And Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Pharma Infrastructure And Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Pharma Infrastructure And Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
